APA (7th ed.) Citation

PDC, G., R, M., O, M., D, D., J, M., J, L., . . . Y, D. (2024). Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials. Journal of clinical and translational science, 8(1), e157. https://doi.org/10.1017/cts.2024.485

Chicago Style (17th ed.) Citation

PDC, Guerra-de-Blas, et al. "Practical Application of Good Participatory Practices for Trials of Emerging Pathogens: Developing Materials for Use in ACTIV-3, -3b, and ACTIV-associated COVID-19 Trials." Journal of Clinical and Translational Science 8, no. 1 (2024): e157. https://doi.org/10.1017/cts.2024.485.

MLA (9th ed.) Citation

PDC, Guerra-de-Blas, et al. "Practical Application of Good Participatory Practices for Trials of Emerging Pathogens: Developing Materials for Use in ACTIV-3, -3b, and ACTIV-associated COVID-19 Trials." Journal of Clinical and Translational Science, vol. 8, no. 1, 2024, p. e157, https://doi.org/10.1017/cts.2024.485.